about
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining f...
Read More
13.47
-0.14
(-1.03%)
6.5M
XNAS Volume
XNAS 10 Apr, 2026 5:30 PM (EDT)
Low Financial Strength
Mid Valuation
Technically Neutral
Await Turnaround
These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks
View Similar
Embed DVM
Viatris Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..